Physician profile
Kevin S Wei
NPI 1114212263
$21,187.88
in general payments reported to CMS, 2019-2025
5 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.35 · 2020: $5,740 · 2022: $2,000 · 2023: $8,717 · 2024: $3,280 · 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $1,487 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $950 · Travel and Lodging: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,169.31 |
| Food and Beverage | $1,486.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $950.00 |
| Travel and Lodging | $780.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $9,206.53 | 2019-2024 | |
| Gilead Sciences, INC. | $7,213.79 | 2020-2024 | |
| Pfizer INC. | $2,339.31 | 2024-2025 | |
| Horizon Therapeutics Plc | $2,000.00 | 2022 | |
| Celgene Corporation | $428.25 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.